Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  L-leucovorin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
Phase III Randomized Study of Immediate vs Delayed 5-FU/L-CF for Colorectal Cancer After Potentially Curative Resection of Liver or Lung Metastases
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CAN-NCIC-CO7, CNR-GIVIO-CO3, EORTC-40923, NCI-V94-0464, CO7
Phase III Randomized Study of 5-FU with High-Dose vs Low-Dose L-CF in Advanced Colorectal Cancer (Summary Last Modified 11/94)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: CNR-GISCAD-011909, EU-93022
Phase III Randomized Study of 5-FU/L-CF/LEV vs 5-FU/L-CF/PLCB, Each with Either High-Dose or Low-Dose L-CF, for Resected Colorectal Cancer (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: NCRI-QUASAR, EU-94045, UKCCCR-QUASAR
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 77
Sponsor: Pharmaceutical / Industry
Protocol IDs: ISO/5FU-10, NCT00195572
Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ACO-002, NCT01290783
PK/PD Investigation of Modufolin® in Plasma, Tumor and Adjacent Mucosa in Patients With Colon Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ISO-CC-002, 2012-000522-22, NCT01681472
Phase II Study of 5-FU/MTX/L-CF for Advanced Colorectal Cancer (Summary Last Modified 07/95)
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: GOCS-09-CR-92, NCI-F95-0028
Phase II Study of 5-FU/L-CF/CDDP (FLP) for Carcinoma of Unknown Primary (Summary Last Modified 06/1999)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SA-JHB-CUP-1, NCI-F95-0033
Phase II Study of Continuous-Infusion L-CF plus 5-FU in Patients with Advanced Colorectal Cancer (Summary Last Modified 06/93)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: DMS-9123, NCI-V92-0054
Phase II Pilot Study of PALA/5-FU Alternating with L-CF/5-FU in Patients with Advanced Colorectal Cancer (Summary Last Modified 10/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CWRCC-1291, NCI-T92-0015D, T92-0015
Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ONCOPTV-01-2012, NCT01533740
Start Over